How good of a bottom fishing candidate is PGNX? Appears that the 50% selloff is due to the likelihood of oral relistor being affected as well.
Any beneficiaries from PGNX's misfortune? IRWD's linaclotide has a pdufa for chronic constipation (not OIC) in september. I assumed NKTR would see a small jump but both NKTR and IRWD have gone down today.
Market Data 
Markets 
AI
